Esophageal squamous cell carcinoma · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Cisplatin and Fluorouracil (CF) Variant #01 | — | R 1 235 | 28d | — | — | 7 | R 8 648 PFS proxy | 2 |
Observation Partial | — | — | — | ~3.4 mo | ~36.1 mo | — | — | 18 |
Placebo Partial | — | — | — | ~3.0 mo | ~6.7 mo | — | — | 38 |
3 of 3 regimens shown